60
Participants
Start Date
October 12, 2021
Primary Completion Date
April 5, 2022
Study Completion Date
April 5, 2022
Neumifil
Neumifil contains the active ingredient HEX17, a multivalent, glycan-targeting carbohydrate binding module (CBM). HEX17 CBM is suspended in an aqueous buffer solution containing 20 mM sodium phosphate, 50 mM NaCl (at pH 6.3), 5 % (v/v) glycerol and 0.5 % (v/v) polysorbate 80.
Placebo
Aqueous buffer solution containing 20 mM sodium phosphate, 50 mM NaCl (at pH 6.3), 5 % (v/v) glycerol and 0.5 % (v/v) polysorbate 80.
Hammersmith Medicines Research (HMR), London
Lead Sponsor
Pneumagen Ltd.
INDUSTRY